Literature DB >> 28570933

The Goldilocks model of immune symbiosis with Mycobacteria and Candida colonizers.

Richard T Robinson1, Anna R Huppler2.   

Abstract

Mycobacteria and Candida species include significant human pathogens that can cause localized or disseminated infections. Although these organisms may appear to have little in common, several shared pathways of immune recognition and response are important for both control and infection-related pathology. In this article, we compare and contrast the innate and adaptive components of the immune system that pertain to these infections in humans and animal models. We also explore a relatively new concept in the mycobacterial field: biological commensalism. Similar to the well-established model of Candida infection, Mycobacteria species colonize their human hosts in equilibrium with the immune response. Perturbations in the immune response permit the progression to pathologic disease at the expense of the host. Understanding the immune factors required to maintain commensalism may aid with the development of diagnostic and treatment strategies for both categories of pathogens.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Candida; Candidiasis; Commensal; Mycobacteria; Nontuberculous; Tuberculosis

Mesh:

Year:  2017        PMID: 28570933      PMCID: PMC5765749          DOI: 10.1016/j.cyto.2017.05.015

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  329 in total

1.  Different Toll-like receptor agonists induce distinct macrophage responses.

Authors:  B W Jones; T K Means; K A Heldwein; M A Keen; P J Hill; J T Belisle; M J Fenton
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

Review 2.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

3.  Mycobacterium branderi from both a hand infection and a case of pulmonary disease.

Authors:  J Wolfe; C Turenne; M Alfa; G Harding; L Thibert; A Kabani
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

4.  Interferon-γ, tumor necrosis factor, and interleukin-18 cooperate to control growth of Mycobacterium tuberculosis in human macrophages.

Authors:  Cory M Robinson; Joo-Yong Jung; Gerard J Nau
Journal:  Cytokine       Date:  2012-06-29       Impact factor: 3.861

5.  Association between sputum smear status and local immune responses at the site of disease in HIV-infected patients with pulmonary tuberculosis.

Authors:  Henry C Mwandumba; S Bertel Squire; Sarah A White; Mukanthu H Nyirenda; Samuel D Kampondeni; Elizabeth R Rhoades; Eduard E Zijlstra; Malcolm E Molyneux; David G Russell
Journal:  Tuberculosis (Edinb)       Date:  2007-10-03       Impact factor: 3.131

6.  Utility of dual skin tests to evaluate tuberculin skin test reactions of 10 to 14 mm in healthcare workers.

Authors:  Bryan J Marsh; Joshua San Vicente; C Fordham von Reyn
Journal:  Infect Control Hosp Epidemiol       Date:  2003-11       Impact factor: 3.254

7.  Genetic and functional analysis of common MRC1 exon 7 polymorphisms in leprosy susceptibility.

Authors:  Andrea Alter; Louis de Léséleuc; Nguyen Van Thuc; Vu Hong Thai; Nguyen Thu Huong; Nguyen Ngoc Ba; Cynthia Chester Cardoso; Audrey Virginia Grant; Laurent Abel; Milton Ozório Moraes; Alexandre Alcaïs; Erwin Schurr
Journal:  Hum Genet       Date:  2009-12-25       Impact factor: 4.132

8.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

9.  X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production.

Authors:  Orchidée Filipe-Santos; Jacinta Bustamante; Margje H Haverkamp; Emilie Vinolo; Cheng-Lung Ku; Anne Puel; David M Frucht; Karin Christel; Horst von Bernuth; Emmanuelle Jouanguy; Jacqueline Feinberg; Anne Durandy; Brigitte Senechal; Ariane Chapgier; Guillaume Vogt; Ludovic de Beaucoudrey; Claire Fieschi; Capucine Picard; Meriem Garfa; Jalel Chemli; Mohamed Bejaoui; Maria N Tsolia; Necil Kutukculer; Alessandro Plebani; Luigi Notarangelo; Christine Bodemer; Frédéric Geissmann; Alain Israël; Michel Véron; Maike Knackstedt; Ridha Barbouche; Laurent Abel; Klaus Magdorf; Dominique Gendrel; Fabrice Agou; Steven M Holland; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

10.  Prospecting environmental mycobacteria: combined molecular approaches reveal unprecedented diversity.

Authors:  Alessandra Pontiroli; Tanya T Khera; Brian B Oakley; Sam Mason; Scot E Dowd; Emma R Travis; Girum Erenso; Abraham Aseffa; Orin Courtenay; Elizabeth M H Wellington
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

View more
  11 in total

1.  Candida albicans Elicits Pro-Inflammatory Differential Gene Expression in Intestinal Peyer's Patches.

Authors:  Navjot Singh; Heather C Kim; Renjie Song; Jaskiran K Dhinsa; Steven R Torres; Magdia De Jesus
Journal:  Mycopathologia       Date:  2019-06-22       Impact factor: 2.574

Review 2.  The Many Hosts of Mycobacteria 8 (MHM8): A conference report.

Authors:  Michelle H Larsen; Karen Lacourciere; Tina M Parker; Alison Kraigsley; Jacqueline M Achkar; Linda B Adams; Kathryn M Dupnik; Luanne Hall-Stoodley; Travis Hartman; Carly Kanipe; Sherry L Kurtz; Michele A Miller; Liliana C M Salvador; John S Spencer; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2020-02-11       Impact factor: 3.131

3.  The many lives of nontuberculous mycobacteria.

Authors:  Tiffany A Claeys; Richard T Robinson
Journal:  J Bacteriol       Date:  2018-02-26       Impact factor: 3.490

Review 4.  The Child with Recurrent Mycobacterial Disease.

Authors:  Brian Reed; William K Dolen
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-23       Impact factor: 4.806

5.  T Cell Production of GM-CSF Protects the Host during Experimental Tuberculosis.

Authors:  Richard T Robinson
Journal:  mBio       Date:  2017-12-12       Impact factor: 7.867

6.  Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c.

Authors:  Manuja Gunasena; Rajni Kant Shukla; Naiquan Yao; Oscar Rosas Mejia; Michael D Powell; Kenneth J Oestreich; Michel de Jesús Aceves-Sánchez; Mario Alberto Flores-Valdez; Namal P M Liyanage; Richard T Robinson
Journal:  Sci Rep       Date:  2022-07-20       Impact factor: 4.996

7.  Inhibition of IL-17A by secukinumab shows no evidence of increased Mycobacterium tuberculosis infections.

Authors:  Michael Kammüller; Tsen-Fang Tsai; Christopher Em Griffiths; Nidhi Kapoor; Pappachan E Kolattukudy; Dominique Brees; Salah-Dine Chibout; Jorge Safi; Todd Fox
Journal:  Clin Transl Immunology       Date:  2017-08-25

8.  Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis.

Authors:  Simone Ribero; Matteo Licciardello; Pietro Quaglino; Paolo Dapavo
Journal:  Case Rep Dermatol       Date:  2019-09-23

Review 9.  Advances in Understanding Human Genetic Variations That Influence Innate Immunity to Fungi.

Authors:  Richard M Merkhofer; Bruce S Klein
Journal:  Front Cell Infect Microbiol       Date:  2020-02-28       Impact factor: 6.073

10.  The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies.

Authors:  Chen-Yu Wu; Hsien-Yi Chiu; Tsen-Fang Tsai
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.